Status:
COMPLETED
Lateral Ridge Augmentation Using Cross-linked or Non-cross-linked Collagen Membrane
Lead Sponsor:
Saint-Joseph University
Conditions:
Bone Loss
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
The objective of the present trial is to test clinically, radiographically and histologically , in a lateral alveolar ridge augmentation model (without simultaneous implant placement) the efficiency i...
Detailed Description
This study is a pilot one, no sample size calculation has been performed. Random allocation was done by the sequentially sealed envelope method. Interventions Pre-operative preparation: * Scaling a...
Eligibility Criteria
Inclusion
- Healthy patients, non-smokers or smokers\<10 cigarettes/day.
- Age between 20 and 75.
- Full mouth bleeding score (FmBS) \<20 %.
- Full mouth plaque score (FmPS) \<15%.
- Presence of a residual alveolar ridge with residual bone width \< 5 mm and adequate
- bone height in the maxilla and the mandible.
- Tooth extraction performed at least 6 weeks before surgery.
- Presence of enough teeth to support an occlusal stent/radiographic guide.
Exclusion
- Systematic diseases.
- History of radiotherapy in the head and neck region in the last 5 years.
- Active periodontitis on the remaining teeth.
- Pregnancy.
- Allergy to collagen.
- Intake of medications that may have an effect on bone turnover and mucosal healing (i.e., tetracycline within the last month, steroids within the last 6 months, bisphosphonates or fluorides at bone therapeutic levels, vitamin D and metabolites at therapeutic levels within the last 6 months).
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04402671
Start Date
March 1 2019
End Date
August 1 2020
Last Update
October 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mario Haddad
Beirut, Lebanon, 1200